GLP3-R is a synthetic peptide studied as a triple-agonist of GLP-1, GIP, and glucagon receptors. Laboratory models evaluate its multi-receptor pharmacology, GPCR signaling dynamics, and downstream molecular pathway interactions. All applications are limited to non-clinical research use.
$65–$159Price range: $65 through $159
Select Dosage :
Buy 2, Get GHK-Cu Free
What It Is
GLP3-R is a synthetic peptide studied as a multi-receptor agonist targeting the glucagon-like peptide-1 receptor (GLP-1R), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon receptor (GCGR) in experimental systems.
What It’s Derived From
GLP3-R is engineered from a modified peptide backbone incorporating structural elements that enable receptor engagement across GLP-1R, GIPR, and GCGR. The molecule includes a lipid side-chain modification designed to enhance molecular stability and prolong activity in controlled laboratory models.
What Research Focuses On
Experimental investigations evaluate GLP3-R in in vitro and in vivo preclinical systems examining multi-receptor incretin pharmacology, GPCR-mediated signaling dynamics, receptor co-activation mechanisms, intracellular cAMP-associated pathways, and downstream metabolic signaling biomarkers under defined laboratory conditions.
This product is indented for research purposes only. All product information is for educational purposes only. This product is not a drug, food or cosmetic.